Novel targeted therapy for gastrointestinal stromal tumors

The focus of cancer therapy is moving towards personalized medicine that has revolutionized treatments of certain cancers, including GIST. Although new GIST therapies have been efficacious and have improved disease outcomes of the patients significantly, they fail frequently and the disease progresses. Therefore, there is a dire need for finding new therapies for GIST patients. We are committed to delivering an innovative, therapeutic option for the patients who have run out of therapy options.

Read more

Upcoming events and news